FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018724145> ?p ?o ?g. }

• W2018724145 endingPage "26773" @default.
• W2018724145 startingPage "26770" @default.
• W2018724145 abstract "Prenylation of the carboxyl-terminal CAAX (C, cysteine; A, aliphatic acid; and X, any amino acid) of Ras is required for its biological activity. We have designed a CAAX peptidomimetic, GGTI-287, which is 10 times more potent toward inhibiting geranylgeranyltransferase I (GGTase I) in vitro (IC50 = 5 nM) than our previously reported farnesyltransferase inhibitor, FTI-276. In whole cells, the methyl ester derivative of GGTI-287, GGTI-286, was 25-fold more potent (IC50 = 2 μM) than the corresponding methyl ester of FTI-276, FTI-277, toward inhibiting the processing of the geranylgeranylated protein Rap1A. Furthermore, GGTI-286 is highly selective for geranylgeranylation over farnesylation since it inhibited the processing of farnesylated H-Ras only at much higher concentrations (IC50 > 30 μM). While the processing of H-Ras was very sensitive to inhibition by FTI-277 (IC50 = 100 nM), that of K-Ras4B was highly resistant (IC50 = 10 μM). In contrast, we found the processing of K-Ras4B to be much more sensitive to GGTI-286 (IC50 = 2 μM). Furthermore, oncogenic K-Ras4B stimulation of mitogen-activated protein (MAP) kinase was inhibited potently by GGTI-286 (IC50 = 1 μM) but weakly by FTI-277 (IC50 = 30 μM). Significant inhibition of oncogenic K-Ras4B stimulation of MAP kinase by GGTI-286 occurred at concentrations (1-3 μM) that did not inhibit oncogenic H-Ras stimulation of MAP kinase. The data presented in this study provide the first demonstration of selective disruption of oncogenic K-Ras4B processing and signaling by a CAAX peptidomimetic. The higher sensitivity of K-Ras4B toward a GGTase I inhibitor has a tremendous impact on future research directions targeting Ras in anticancer therapy. Prenylation of the carboxyl-terminal CAAX (C, cysteine; A, aliphatic acid; and X, any amino acid) of Ras is required for its biological activity. We have designed a CAAX peptidomimetic, GGTI-287, which is 10 times more potent toward inhibiting geranylgeranyltransferase I (GGTase I) in vitro (IC50 = 5 nM) than our previously reported farnesyltransferase inhibitor, FTI-276. In whole cells, the methyl ester derivative of GGTI-287, GGTI-286, was 25-fold more potent (IC50 = 2 μM) than the corresponding methyl ester of FTI-276, FTI-277, toward inhibiting the processing of the geranylgeranylated protein Rap1A. Furthermore, GGTI-286 is highly selective for geranylgeranylation over farnesylation since it inhibited the processing of farnesylated H-Ras only at much higher concentrations (IC50 > 30 μM). While the processing of H-Ras was very sensitive to inhibition by FTI-277 (IC50 = 100 nM), that of K-Ras4B was highly resistant (IC50 = 10 μM). In contrast, we found the processing of K-Ras4B to be much more sensitive to GGTI-286 (IC50 = 2 μM). Furthermore, oncogenic K-Ras4B stimulation of mitogen-activated protein (MAP) kinase was inhibited potently by GGTI-286 (IC50 = 1 μM) but weakly by FTI-277 (IC50 = 30 μM). Significant inhibition of oncogenic K-Ras4B stimulation of MAP kinase by GGTI-286 occurred at concentrations (1-3 μM) that did not inhibit oncogenic H-Ras stimulation of MAP kinase. The data presented in this study provide the first demonstration of selective disruption of oncogenic K-Ras4B processing and signaling by a CAAX peptidomimetic. The higher sensitivity of K-Ras4B toward a GGTase I inhibitor has a tremendous impact on future research directions targeting Ras in anticancer therapy." @default.
• W2018724145 created "2016-06-24" @default.
• W2018724145 creator A5021167157 @default.
• W2018724145 creator A5040956720 @default.
• W2018724145 creator A5044268981 @default.
• W2018724145 creator A5056350826 @default.
• W2018724145 date "1995-11-01" @default.
• W2018724145 modified "2023-10-15" @default.
• W2018724145 title "Disruption of Oncogenic K-Ras4B Processing and Signaling by a Potent Geranylgeranyltransferase I Inhibitor" @default.
• W2018724145 cites W1503798699 @default.
• W2018724145 cites W1507719842 @default.
• W2018724145 cites W1572144604 @default.
• W2018724145 cites W1580583692 @default.
• W2018724145 cites W1589687205 @default.
• W2018724145 cites W1607745865 @default.
• W2018724145 cites W1635320150 @default.
• W2018724145 cites W1784068511 @default.
• W2018724145 cites W1964882540 @default.
• W2018724145 cites W1977345497 @default.
• W2018724145 cites W1982933055 @default.
• W2018724145 cites W1986280661 @default.
• W2018724145 cites W1993418815 @default.
• W2018724145 cites W2002292023 @default.
• W2018724145 cites W2017098460 @default.
• W2018724145 cites W2026834760 @default.
• W2018724145 cites W2036082581 @default.
• W2018724145 cites W2037480365 @default.
• W2018724145 cites W2048983596 @default.
• W2018724145 cites W2051571002 @default.
• W2018724145 cites W2056942156 @default.
• W2018724145 cites W2061234826 @default.
• W2018724145 cites W2081534605 @default.
• W2018724145 cites W2083506343 @default.
• W2018724145 cites W2086589373 @default.
• W2018724145 cites W2089906643 @default.
• W2018724145 cites W2098806204 @default.
• W2018724145 cites W2107666634 @default.
• W2018724145 cites W2133362776 @default.
• W2018724145 cites W2184141090 @default.
• W2018724145 cites W4232777855 @default.
• W2018724145 cites W4246808803 @default.
• W2018724145 doi "https://doi.org/10.1074/jbc.270.45.26770" @default.
• W2018724145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7592913" @default.
• W2018724145 hasPublicationYear "1995" @default.
• W2018724145 type Work @default.
• W2018724145 sameAs 2018724145 @default.
• W2018724145 citedByCount "172" @default.
• W2018724145 countsByYear W20187241452012 @default.
• W2018724145 countsByYear W20187241452013 @default.
• W2018724145 countsByYear W20187241452014 @default.
• W2018724145 countsByYear W20187241452015 @default.
• W2018724145 countsByYear W20187241452016 @default.
• W2018724145 countsByYear W20187241452017 @default.
• W2018724145 countsByYear W20187241452018 @default.
• W2018724145 countsByYear W20187241452019 @default.
• W2018724145 countsByYear W20187241452020 @default.
• W2018724145 countsByYear W20187241452021 @default.
• W2018724145 countsByYear W20187241452022 @default.
• W2018724145 countsByYear W20187241452023 @default.
• W2018724145 crossrefType "journal-article" @default.
• W2018724145 hasAuthorship W2018724145A5021167157 @default.
• W2018724145 hasAuthorship W2018724145A5040956720 @default.
• W2018724145 hasAuthorship W2018724145A5044268981 @default.
• W2018724145 hasAuthorship W2018724145A5056350826 @default.
• W2018724145 hasBestOaLocation W20187241451 @default.
• W2018724145 hasConcept C181199279 @default.
• W2018724145 hasConcept C184235292 @default.
• W2018724145 hasConcept C185592680 @default.
• W2018724145 hasConcept C202751555 @default.
• W2018724145 hasConcept C23167141 @default.
• W2018724145 hasConcept C2777752497 @default.
• W2018724145 hasConcept C2778396349 @default.
• W2018724145 hasConcept C55493867 @default.
• W2018724145 hasConcept C57790582 @default.
• W2018724145 hasConcept C86803240 @default.
• W2018724145 hasConceptScore W2018724145C181199279 @default.
• W2018724145 hasConceptScore W2018724145C184235292 @default.
• W2018724145 hasConceptScore W2018724145C185592680 @default.
• W2018724145 hasConceptScore W2018724145C202751555 @default.
• W2018724145 hasConceptScore W2018724145C23167141 @default.
• W2018724145 hasConceptScore W2018724145C2777752497 @default.
• W2018724145 hasConceptScore W2018724145C2778396349 @default.
• W2018724145 hasConceptScore W2018724145C55493867 @default.
• W2018724145 hasConceptScore W2018724145C57790582 @default.
• W2018724145 hasConceptScore W2018724145C86803240 @default.
• W2018724145 hasIssue "45" @default.
• W2018724145 hasLocation W20187241451 @default.
• W2018724145 hasOpenAccess W2018724145 @default.
• W2018724145 hasPrimaryLocation W20187241451 @default.
• W2018724145 hasRelatedWork W1988619041 @default.
• W2018724145 hasRelatedWork W1994968074 @default.
• W2018724145 hasRelatedWork W2002252224 @default.
• W2018724145 hasRelatedWork W2036974504 @default.
• W2018724145 hasRelatedWork W2041797886 @default.
• W2018724145 hasRelatedWork W2064068411 @default.
• W2018724145 hasRelatedWork W2079195006 @default.
• W2018724145 hasRelatedWork W2094377607 @default.
• W2018724145 hasRelatedWork W2163444398 @default.

• next